Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) Peptid

CDKN1B Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974784

Kurzübersicht für Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) Peptid (ABIN974784)

Target

CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))

Spezies

Human

Quelle

  • 12
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-CDKN1B antibody (Catalog #: AVARP03039_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))

    Hintergrund

    CDKN1B is a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. It binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state.This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: CDKN4, KIP1, MEN1B, MEN4, P27KIP1

    Protein Interaction Partner: FOXO3,CCNA1,CCNA2,CCNA2,CCNA2,CCND1,CCNE1,CCNE1,CDK2,CDK2,CDK2,COPS5,E1A,E1A,KPNA2,SKP2,SKP2,STMN1,UBB,XPO1,ABL1,AKT1,ARHGDIA,CASP8,CCNA1,CCNA2,CCNB1,CCND1,CCND2,CCND3,CCNE2,CDK2,CDK3,CDK4,CDK5,CKS1B,COPS5,CUL4A,GRB2,KPNA3,KPNA5,LYN,MCM7,NUP50,SKP2,SRC,STMN1,TRAF2,TSC2,UBB,UCHL1,XPO1,YES1,YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,AKT1,ARHGDIA,CCNA1,CCNA2,CCND1,CCND2,CCND3,CCNE1,CDC34,CDK2,CDK4,CDK6,CKS1B,COPS5,CUL4A,GRB2,NUP50,SKP2,SPDYA,TRAF2,TSC1,TSC2,UBE2B,UBE2D2,UCHL1,XPO1,YWHAQ

    Protein Size: 198

    Molekulargewicht

    22 kDa

    Gen-ID

    1027

    NCBI Accession

    NM_004064, NP_004055

    UniProt

    P46527
Sie sind hier:
Chat with us!